» Articles » PMID: 31392561

The Prevalence of Type 2 Diabetes and Associated Risk Factors with Generalized Osteoarthritis: a Retrospective Study Using ICD Codes for Clinical Data Repository System

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2019 Aug 9
PMID 31392561
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Type 2 diabetes mellitus (T2DM) has been associated with osteoarthritis (OA). T2DM may be associated with generalized OA (GOA ≥ 3 joints) rather than localized OA (LOA < 3 joints). The purpose of this study was to examine the prevalence of T2DM in people with GOA compared with LOA and to investigate the association between demographic risk factors and chronic diseases (i.e., T2DM, hypertension, dyslipidemia, neuropathy, and body mass index (BMI)) with GOA compared with LOA.

Methods: A retrospective review of data was performed, and patients with diagnostic codes for OA were selected. Identified codes included primary GOA, primary LOA, T2DM, hypertension, dyslipidemia, neuropathy, depression, anxiety, and sleep disorders. Information about BMI and medication list was obtained. Chi-square and logistic regression were performed to examine the prevalence and risk factors, respectively.

Results: Data from 3855 patients (mean age = 66.43 ± 11.02, 60.9% women) included patients with GOA (n = 1265) and LOA (n = 2590). The prevalence of T2DM was significantly greater among patients with GOA (25.8%) compared with those with LOA (12.0%); however, the GOA group were older. Based on age groups, T2DM was prevalent in 17.8% of GOA compared with 7.2% in LOA for younger adults (aged 45-64 years) and was prevalent in 28.8% of GOA compared with 15.7% in LOA for older adults (aged 65 years or older). The odds ratio of GOA increased in people with chronic diseases compared with those without including T2DM (odds ratio (OR) 1.37, 95% confidence interval (CI) 1.05-1.78, p = 0.02), hypertension (OR 1.99, CI 1.63-2.43, p < 0.001), and dyslipidemia (OR 3.46, CI 2.86-4.19, p < 0.001), adjusting for covariates.

Conclusion: Higher prevalence of T2DM was found in people with GOA when compared with LOA across both age groups. T2DM, hypertension, and dyslipidemia were associated with GOA. Future research with longitudinal designs is needed to test the causality of this association.Key Points• The prevalence of type 2 diabetes in people with generalized osteoarthritis was almost double compared with localized osteoarthritis, although generalized osteoarthritis group were older.• Among people with osteoarthritis, the risk of generalized osteoarthritis is increased by 37% when people had type 2 diabetes, by 99% when people had hypertension, and by 246% when people had dyslipidemia.

Citing Articles

Prevalence of multiple long-term chronic conditions and associated disabilities among community-dwelling adults in Riyadh.

Alenazi A, Alhwoaimel N, Alqahtani B, Alshehri M, Alhowimel A, Khunti K Front Public Health. 2024; 12:1275124.

PMID: 39421811 PMC: 11484829. DOI: 10.3389/fpubh.2024.1275124.


Diabetes is associated with longitudinal declined physical performance measures in persons with or at risk of knee osteoarthritis: data from the Osteoarthritis Initiative.

Alenazi A, Alqahtani B Eur J Phys Rehabil Med. 2024; 60(3):496-504.

PMID: 38647532 PMC: 11258910. DOI: 10.23736/S1973-9087.24.08034-1.


Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized....

Langworthy M, Lascarides P, Ngai W, Steele K, Huang Y Drugs Context. 2024; 13.

PMID: 38601838 PMC: 11006243. DOI: 10.7573/dic.2023-11-3.


Osteoarthritis and Diabetes: Where Are We and Where Should We Go?.

Alenazi A, Alhowimel A, Alshehri M, Alqahtani B, Alhwoaimel N, Segal N Diagnostics (Basel). 2023; 13(8).

PMID: 37189487 PMC: 10137010. DOI: 10.3390/diagnostics13081386.


National and regional prevalence rates of hypertension in Saudi Arabia: A descriptive analysis using the national survey data.

Alenazi A, Alqahtani B Front Public Health. 2023; 11:1092905.

PMID: 37081959 PMC: 10110943. DOI: 10.3389/fpubh.2023.1092905.


References
1.
Harman D . The biologic clock: the mitochondria?. J Am Geriatr Soc. 1972; 20(4):145-7. DOI: 10.1111/j.1532-5415.1972.tb00787.x. View

2.
Driban J, Lo G, Eaton C, Lapane K, Nevitt M, Harvey W . Exploratory analysis of osteoarthritis progression among medication users: data from the Osteoarthritis Initiative. Ther Adv Musculoskelet Dis. 2017; 8(6):207-219. PMC: 5322858. DOI: 10.1177/1759720X16664323. View

3.
Park H, Im S, Kim H, Jung S, Kim D, Jang E . Validation of algorithms to identify knee osteoarthritis patients in the claims database. Int J Rheum Dis. 2019; 22(5):890-896. DOI: 10.1111/1756-185X.13470. View

4.
Mozaffarian D, Benjamin E, Go A, Arnett D, Blaha M, Cushman M . Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016; 133(4):447-54. DOI: 10.1161/CIR.0000000000000366. View

5.
Sale J, Gignac M, Hawker G . The relationship between disease symptoms, life events, coping and treatment, and depression among older adults with osteoarthritis. J Rheumatol. 2008; 35(2):335-42. View